Steward Partners Investment Advisory’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $687K | Buy |
30,419
+10,230
| +51% | +$227K | ﹤0.01% | 1355 |
|
|
2025
Q4 | $522K | Buy |
+20,189
| New | +$480K | ﹤0.01% | 1396 |
|
|
2024
Q4 | – | Sell |
-1,100
| Closed | -$16.6K | – | 4063 |
|
|
2024
Q3 | $16.6K | Buy |
1,100
+200
| +22% | +$3.42K | ﹤0.01% | 2737 |
|
|
2024
Q2 | $25.7K | Buy |
900
+35
| +4% | +$996 | ﹤0.01% | 2412 |
|
|
2024
Q1 | $25.3K | Hold |
865
| – | – | ﹤0.01% | 2420 |
|
|
2023
Q4 | $29.2K | Sell |
865
-150
| -15% | -$4.39K | ﹤0.01% | 2213 |
|
|
2023
Q3 | $31.1K | Buy |
1,015
+185
| +22% | +$6.67K | ﹤0.01% | 2119 |
|
|
2023
Q2 | $33.3K | Buy |
830
+65
| +8% | +$2.69K | ﹤0.01% | 2054 |
|
|
2023
Q1 | $31.2K | Sell |
765
-120
| -14% | -$4.77K | ﹤0.01% | 2062 |
|
|
2022
Q4 | $34.2K | Sell |
885
-50
| -5% | -$2.43K | ﹤0.01% | 1985 |
|
|
2022
Q3 | $50K | Hold |
935
| – | – | ﹤0.01% | 1788 |
|
|
2022
Q2 | $55K | Hold |
935
| – | – | ﹤0.01% | 1761 |
|
|
2022
Q1 | $71K | Hold |
935
| – | – | ﹤0.01% | 1750 |
|
|
2021
Q4 | $56K | Sell |
935
-175
| -16% | -$9.65K | ﹤0.01% | 1857 |
|
|
2021
Q3 | $62K | Hold |
1,110
| – | – | ﹤0.01% | 1777 |
|
|
2021
Q2 | $67K | Sell |
1,110
-210
| -16% | -$13.3K | ﹤0.01% | 2789 |
|
|
2021
Q1 | $92.5K | Buy |
1,320
+75
| +6% | +$5.36K | ﹤0.01% | 1669 |
|
|
2020
Q4 | $75K | Sell |
1,245
-65
| -5% | -$3.81K | ﹤0.01% | 1485 |
|
|
2020
Q3 | $79K | Buy |
1,310
+5
| +0.4% | +$291 | ﹤0.01% | 1309 |
|
|
2020
Q2 | $68K | Sell |
1,305
-99
| -7% | -$4.14K | ﹤0.01% | 1291 |
|
|
2020
Q1 | $47K | Sell |
1,404
-535
| -28% | -$22.2K | ﹤0.01% | 1287 |
|
|
2019
Q4 | $87K | Sell |
1,939
-90
| -4% | -$3.82K | ﹤0.01% | 1182 |
|
|
2019
Q3 | $77K | Buy |
2,029
+379
| +23% | +$15.1K | ﹤0.01% | 1190 |
|
|
2019
Q2 | $71K | Buy |
+1,650
| New | +$70.1K | ﹤0.01% | 1199 |
|
Other funds holding PCRX
DPCM
VPM
VCM
